MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Bioventus P/CF Ratio 2011-2026 | BVS
Annual P/CF Ratio Bioventus
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.14 | 15.2 | 22.9 | -6.08 | 25.8 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 25.8 | -6.08 | 13.2 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Castle Biosciences
CSTL
|
7.33 | $ 24.75 | - | $ 717 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 17.01 | - | $ 179 M |  China |
 |
Agilent Technologies
A
|
28.3 | $ 117.69 | - | $ 35.8 B | USA |
 |
Medpace Holdings
MEDP
|
18.2 | $ 426.79 | - | $ 12.3 B | USA |
 |
Myriad Genetics
MYGN
|
227 | $ 4.11 | - | $ 381 M | USA |
 |
NeoGenomics
NEO
|
284 | $ 8.89 | - | $ 1.14 B | USA |
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M |  Canada |
 |
National Research Corporation
NRC
|
11.9 | $ 17.86 | -4.7 % | $ 400 M | USA |
 |
Natera
NTRA
|
-12.3 | $ 215.09 | - | $ 21.2 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.23 | - | $ 25.8 B |  Niderland |
 |
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | USA |
 |
Personalis
PSNL
|
-5.62 | $ 6.07 | - | $ 360 M | USA |
 |
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | USA |
 |
Soleno Therapeutics
SLNO
|
44.5 | $ 52.94 | - | $ 2.69 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
23.6 | $ 20.95 | - | $ 1.12 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
-0.201 | $ 1.64 | - | $ 2.18 M | USA |
 |
Thermo Fisher Scientific
TMO
|
25.1 | $ 472.95 | - | $ 178 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-32.8 | $ 59.53 | - | $ 3.56 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
10.4 | $ 181.73 | - | $ 9.01 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | USA |
 |
Waters Corporation
WAT
|
30.1 | $ 349.53 | -0.08 % | $ 20.8 B | USA |
 |
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
22.2 | $ 14.92 | - | $ 451 M | USA |
 |
Guardant Health
GH
|
-72.7 | $ 92.25 | - | $ 11.6 B | USA |
 |
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
12.9 | $ 124.13 | - | $ 10.2 B |  Irlanda |
 |
Illumina
ILMN
|
19.6 | $ 142.58 | - | $ 22.7 B | USA |
 |
Senseonics Holdings
SENS
|
-5.93 | $ 5.36 | - | $ 224 M | USA |
 |
Interpace Biosciences
IDXG
|
1.26 | $ 2.11 | 5.09 % | $ 9.33 M | USA |
 |
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-1.87 | $ 2.21 | - | $ 5.08 M | USA |
 |
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.6 | - | $ 216 M | Irlanda |
 |
Lantheus Holdings
LNTH
|
13.1 | $ 86.15 | - | $ 5.81 B | USA |
 |
Exagen
XGN
|
-5.14 | $ 3.09 | - | $ 66.6 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 256.94 | - | $ 21.4 B | USA |
 |
Celcuity
CELC
|
-35 | $ 139.44 | - | $ 6.52 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
17.5 | $ 9.18 | - | $ 1.99 B | USA |